Responses
Clinical/translational cancer immunotherapy
Original research
Combination immunotherapy with nivolumab and ipilimumab in patients with rare gynecological malignancies: results of the CA209-538 clinical trial
Compose a Response to This Article
Other responses
No responses have been published for this article.